PMOS symptoms are easy to miss — and even easier to dismiss. You eat well. You exercise. You do everything right — and yet your period arrives when it feels like it, your skin keeps breaking out along your jawline, and the weight around your middle refuses to move no matter what you try.
If this pattern sounds familiar, you’re not failing at health. You might be dealing with a hormonal condition that affects 1 in 10 women of reproductive age — often for years before it gets a name.
PMOS — Polyendocrine Metabolic Ovarian Syndrome (formerly PCOS) — is one of the most common hormonal disorders in women, and one of the most underdiagnosed. The average time from first symptoms to diagnosis is two years. Two years of being told your irregular periods are “just stress” or your acne is “just hormones” without anyone connecting the dots.
This article gives you the full picture: what PMOS actually is, the 7 symptoms that often get missed, how it’s properly diagnosed using the updated 2023 criteria, and what the evidence says about managing it naturally.
Does This Sound Like You?
Most women with PMOS recognise themselves in several of these — often after years of being told each one is unrelated.
- ✓Your period arrives when it feels like it — sometimes 35 days, sometimes 60, sometimes not at all
- ✓Persistent fatigue even when you sleep enough hours
- ✓Mood swings, anxiety, or low mood that feel hormonal but get dismissed
- ✓Deep, painful breakouts along your jawline and chin that topical treatments don’t touch
- ✓Coarse dark hair appearing in places it didn’t used to — face, chest, abdomen, or back
- ✓Hair thinning at your crown, temples, or part line
- ✓Weight gain around your midsection that doesn’t respond to eating less or moving more
- ✓You’ve been told it’s “just stress” or “just hormones” for years without a clear answer
Not all PMOS presents the same way. The four most common patterns — insulin-resistant, inflammatory, adrenal-driven, and post-pill — respond best to different interventions. This 2-minute assessment identifies yours and delivers a personalised action plan.
Take the 2-Minute PMOS Pattern Assessment →
What PMOS Actually Is
The old name was misleading. PCOS — Polycystic Ovary Syndrome — implied the condition was defined by ovarian cysts. It isn’t. Many women with the condition don’t have visible cysts at all. The 2026 renaming to PMOS (Polyendocrine Metabolic Ovarian Syndrome) corrects this: the new name reflects the condition’s actual drivers — its endocrine, metabolic, and systemic features — rather than how the ovaries look on an ultrasound scan. The Lancet authors specifically chose “polyendocrine metabolic” because the condition affects hormones, metabolism, weight, mental health, and skin — not just ovarian morphology.
At its core, PMOS is driven by three biological mechanisms that interact and reinforce each other. Understanding which one is most active in your body is what makes targeted intervention possible.
Women with PMOS produce higher-than-normal levels of testosterone and DHT. These androgens disrupt ovulation, drive the skin and hair changes, and create most of the visible symptoms — jawline acne, scalp thinning, excess facial hair. What makes this mechanism frustrating is that it is self-reinforcing: androgen excess reduces insulin sensitivity, which drives more androgen production.
Approximately 65–70% of women with PMOS have some degree of insulin resistance. When cells stop responding normally to insulin, the pancreas produces more — and high insulin acts directly on ovarian theca cells to produce even more androgens. This is why abdominal weight gain in PMOS is largely metabolic, not caloric: you can eat the same as someone without PMOS and store fat differently because the insulin signalling itself is disrupted.
The androgen excess and insulin resistance together interfere with the normal development and release of eggs. Without ovulation, the hormonal cascade that triggers a period does not complete — cycles become irregular or stop. This is why PMOS is the leading cause of ovulatory infertility. But it also means that restoring ovulation is possible: when insulin resistance and androgen excess are addressed, ovulation often resumes.
Start Here
The 7 Core PMOS Symptoms — Including the Ones That Get Missed
PMOS symptoms present differently in different women. Some have the full classic picture; others show only one or two signs for years. Tap any symptom to understand the mechanism behind it.
The most diagnostic symptom. With PMOS, ovulation is disrupted — without ovulation, the hormonal cascade that triggers a period does not complete normally. Cycles may run 35–90+ days, or stop entirely for months. This is sometimes dismissed as “stress” for years before PMOS is considered.
Mechanism: androgen excess + insulin resistance → disrupted ovulation → irregular periodsInsulin resistance drives fat storage, particularly visceral (abdominal) fat. This fat is metabolically active — it produces inflammatory compounds that worsen insulin resistance further. The frustrating part: this weight is largely metabolic, not caloric. You can eat the same as someone without PMOS and store fat differently.
Mechanism: insulin resistance → visceral fat → inflammation → more insulin resistanceElevated androgens increase sebum production. The result: deep, cystic acne concentrated along the jawline, chin, and upper neck — a characteristic pattern that distinguishes hormonal acne from stress or dietary breakouts. Standard topical treatments often fail because the root cause is internal.
Mechanism: elevated androgens → excess sebum → cystic jawline/chin acne→ Hormonal Acne: Root Causes and Evidence-Based ManagementThe same androgen excess that drives acne causes coarse, dark hair to grow on the face, chest, abdomen, or back. Simultaneously, scalp hair thins at the crown — in a pattern similar to androgenic alopecia. Both are driven by the same hormonal mechanism.
Mechanism: elevated DHT → hirsutism + scalp follicle miniaturisationOften treated as separate issues unrelated to PMOS. A 2018 meta-analysis in Fertility and Sterility found women with PMOS have 3× higher rates of anxiety and depression than age-matched controls. The mechanisms are multiple: androgen excess affects neurotransmitters directly; insulin resistance drives inflammation that impacts mood; and sleep disruption compounds both.
Mechanism: hormonal imbalance + HPA dysregulation + inflammation → mood disruptionInsulin resistance disrupts cellular energy production, contributing to persistent fatigue despite adequate sleep. Women with PMOS have up to 9× the sleep apnea risk of women without the condition — massively underdiagnosed and compounding every other symptom. Sleep apnea cannot be addressed by supplements and requires clinical evaluation.
Mechanism: insulin resistance → energy disruption + elevated sleep apnea risk (clinical assessment required)PMOS is the leading cause of ovulatory infertility — accounting for approximately 80% of anovulatory infertility cases. Without regular ovulation, conception is significantly harder. The important note: PMOS-related infertility is highly treatable. Most women with PMOS who want to conceive can do so with appropriate medical support including ovulation induction, letrozole, or IVF where indicated.
Mechanism: androgen excess + insulin resistance → anovulation → ovulatory infertilityHow PMOS Is Diagnosed — Updated 2023 Criteria
There is no single test for PMOS. Diagnosis uses the Rotterdam criteria, updated in the 2023 International Evidence-Based Guidelines, which require meeting at least 2 of the following 3 conditions. Tap each tab to understand what it means clinically:
Irregular or absent ovulation
Cycles longer than 35 days, fewer than 8 periods per year, or complete absence of periods. Reflects anovulation — follicles not maturing and releasing eggs normally. A day-21 progesterone blood test can confirm whether ovulation occurred in a given cycle.
Clinical or biochemical hyperandrogenism
Clinical signs: persistent acne (especially jawline/chin), hirsutism (Ferriman-Gallwey score ≥4–6), or androgenic alopecia (scalp hair thinning).
Biochemical: elevated total or free testosterone, elevated DHEA-S, or elevated androstenedione on blood testing.
You do not need an elevated blood test if you have visible androgen effects. Conversely, elevated androgens on blood test without visible signs also meets the criterion.
Polycystic ovarian morphology
By ultrasound: 20 or more follicles per ovary, OR a single ovary measuring more than 10ml in volume.
2023 update: AMH (anti-Müllerian hormone) blood testing is now the preferred method — more objective, not affected by cycle timing or operator variation. An elevated AMH is now accepted as an alternative to ultrasound. See: Redefining PCOS: 2023 Guidelines (PMC) →
You do NOT need polycystic ovaries to be diagnosed with PMOS. If you meet criteria 1 and 2, the diagnosis is made without this criterion.
Your clinician will typically start with a symptom history, followed by a blood panel and — if indicated — a pelvic ultrasound. The blood panel should include: total and free testosterone, DHEA-S, LH and FSH, estradiol, fasting glucose and fasting insulin, thyroid panel (TSH, free T3, free T4), and prolactin.
PMOS symptoms rarely happen in isolation.
The same hormonal imbalance affecting your ovaries and your cycle is also affecting the rest of your body — simultaneously. That is why PMOS so often gets dismissed: each symptom is treated as unrelated, when in reality they are all expressions of the same underlying mechanism.
This is not you failing at multiple things at once. It is one hormonal condition expressing itself across multiple systems.
Natural Management for PMOS — What the Evidence Actually
There is no cure for PMOS, and PMOS symptoms cannot be eliminated entirely. But PMOS is highly responsive to lifestyle intervention — more so than most chronic conditions. Both primary drivers (insulin resistance and inflammation) are directly modifiable through diet, exercise, and targeted supplementation. The 2023 International Evidence-Based PMOS Guideline explicitly recommends lifestyle intervention as first-line treatment before medication for most women.
Diet — the Single Highest-Impact Lever
Because insulin resistance is central to PMOS, blood sugar management is the dietary priority. The best-evidenced approaches:
- Low-glycaemic diet — choose foods that release glucose slowly: whole grains, legumes, non-starchy vegetables, berries. A 2020 RCT in Nutrients found low-GI diet significantly improved menstrual regularity, androgen levels, and insulin markers in women with PMOS versus standard diet.
- Anti-inflammatory foods — extra-virgin olive oil, fatty fish (salmon, sardines, mackerel), walnuts, leafy greens. Systemic inflammation in PMOS amplifies insulin resistance — reducing it through diet addresses both pathways simultaneously.
- Adequate protein — 25–30g per meal stabilises blood sugar and supports satiety, reducing insulin-spiking snacking patterns.
- Cruciferous vegetables — broccoli, cauliflower, kale, Brussels sprouts contain DIM (diindolylmethane), which supports healthy oestrogen metabolism and androgen clearance via the liver.
Exercise — Type Matters as Much as Frequency
Exercise improves insulin sensitivity more effectively than most medications. Resistance training (2–3× per week) builds muscle tissue that acts as a glucose sink — improving insulin sensitivity durably. A 2023 systematic review in Frontiers in Physiology found resistance training significantly reduced fasting insulin, testosterone, and BMI in women with PMOS.
Low-to-moderate intensity cardio complements this — daily walking has strong evidence for improving insulin sensitivity without the cortisol cost of high-intensity training. HIIT remains a recommended modality in PMOS guidelines and is appropriate when stress and fatigue levels allow. If you are exhausted, lighter and more consistent beats harder and sporadic.
Supplements with Clinical Evidence for PMOS
These supplements have documented clinical evidence specifically for PMOS-related outcomes. They are adjuncts to lifestyle intervention — not replacements for medical treatment. Tap each to see the evidence, dose, contraindications, and recommended product.
Activates AMPK — the same metabolic pathway as metformin — improving insulin sensitivity, reducing androgens, and may support restoration of ovulation. A 2019 meta-analysis found berberine comparable to metformin for improving metabolic and hormonal markers in women with PMOS. Particularly effective when insulin resistance is the dominant driver.
KSM-66 ashwagandha is the most clinically studied adaptogen for cortisol reduction. A 2012 RCT (Chandrasekhar et al., PMID 23439798) found KSM-66 reduced cortisol by 14–27% and significantly improved stress scores versus placebo. For adrenal-driven PMOS, addressing cortisol reduces one of the primary androgen pathways. Allow 6–8 weeks for full effect.
Magnesium deficiency may worsen insulin resistance independently. A 2017 RCT found magnesium supplementation improved fasting insulin and testosterone in women with PMOS. It may also support cortisol regulation — relevant because HPA axis dysregulation in PMOS creates a cortisol-androgen feedback loop. Glycinate form has the highest bioavailability and causes no laxative effect at standard doses. The Clear Wellness 360 formula adds D3 and K2, which support bone health and immune function — particularly relevant in PMOS where vitamin D deficiency is common.
When to Work With a Clinician
Natural approaches are powerful but not sufficient for every presentation. Medical treatment is appropriate — and often necessary — in these situations:
- Periods have stopped entirely for 3+ months — uterine lining protection is a clinical priority
- Fertility goals not being met after 6–12 months of trying with irregular cycles
- Severe acne or hirsutism not responding to lifestyle changes after 3–6 months
- Mental health significantly impacted — PMOS-related depression and anxiety deserve direct treatment
- Metabolic markers not improving after 3–6 months of consistent lifestyle intervention
Look for a clinician who runs the full PMOS blood panel — fasting insulin, full androgen profile, LH/FSH, thyroid, and prolactin — and who understands the interplay between insulin resistance and androgen excess. Midi Health specialises in women’s hormonal conditions including PMOS, running comprehensive testing from a home telehealth appointment.
A print-ready, clinician-friendly tracker built around the diagnostic criteria above. Take it to your next GP appointment and shortcut the diagnosis pathway most women spend two years navigating.
- ✓30-day symptom tracker covering cycle length, skin, hair, mood, energy, and weight
- ✓The exact blood panel to request — printable for your GP
- ✓The Rotterdam criteria explained in plain language
- ✓A symptom-to-pattern decoder matching your tracked symptoms to the four PMOS patterns
- ✓Questions to ask your clinician at your diagnosis appointment
PMOS symptoms are not something you simply endure. The condition has specific, modifiable drivers — and lifestyle intervention addresses those drivers directly. Diet quality, exercise type, insulin management, and targeted supplementation produce measurable improvements in the same markers that medications target.
The most important thing you can do today: get an accurate diagnosis. From there, the path is clear.
Frequently Asked Questions
PMOS is considered a chronic hormonal and metabolic condition rather than a temporary state. However, symptoms often improve significantly — and in some cases resolve — with sustained lifestyle intervention. Many women experience dramatic reduction in symptoms, restoration of regular cycles, and normalisation of metabolic markers through diet, resistance training, and targeted supplementation. “Going away” is less accurate than “becoming well managed.”
Yes. The updated 2023 Rotterdam criteria require only 2 of 3 conditions to be met — irregular ovulation is one criterion, but PMOS can be diagnosed with elevated androgens and ovarian morphology (or elevated AMH) alone. Women with regular cycles who have elevated androgens, androgen-driven skin symptoms, and polycystic ovarian morphology on ultrasound or AMH blood test can receive a PMOS diagnosis without irregular periods.
Berberine is one of the most clinically studied natural compounds for PMOS, with a meta-analysis of 7 RCTs showing comparable efficacy to metformin for metabolic and hormonal markers. It is generally well tolerated at 500mg 2–3× daily with meals. However, it is contraindicated in pregnancy and breastfeeding, inhibits CYP450 liver enzymes (meaning it can interact with prescription medications including metformin and hormonal contraceptives), and is not suitable for people with liver disease. Always discuss with your GP or pharmacist before starting, particularly if on any prescription medication.
PMOS and endometriosis are distinct conditions that can co-exist. PMOS is a hormonal and metabolic disorder characterised by androgen excess, insulin resistance, and ovulatory dysfunction. Endometriosis is a condition where tissue similar to the uterine lining grows outside the uterus, causing pain, inflammation, and often heavy or painful periods. PMOS typically causes irregular or absent periods and androgen-driven symptoms (acne, hirsutism). Endometriosis typically causes painful, heavy periods and pelvic pain. They require different diagnostic approaches and different treatments, and both require clinical diagnosis.
The Lancet published a multistep global consensus process in May 2026 (Teede HJ et al., DOI: 10.1016/S0140-6736(26)00717-8) proposing the renaming from PCOS to PMOS — Polyendocrine Metabolic Ovarian Syndrome. The old name “Polycystic Ovary Syndrome” was considered misleading because it implied the condition is defined by ovarian cysts, when in fact many women with PMOS don’t have cysts at all. The new name reflects what the condition actually is: a multisystem endocrine and metabolic disorder affecting hormones, metabolism, weight, mental health, and skin. The condition itself, its diagnostic criteria, and all treatments remain unchanged.
